View This Report »
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects Summary Type 2 diabetes ...
DelveInsight “Diabetic foot ulcers (DFUs) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Diabetic foot ulcers (DFUs) in seven major markets (US, France, Germany, ...
DelveInsight’s, “ Diabetic Foot Ulcers-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Diabetic Foot Ulcers. The D ...